| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |